Recruiting Lymphoma Studies in Whittier
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of zilovertamab vedotin (ZV) in combination with standa...
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) ...
About Lymphoma Clinical Trials in Whittier
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Whittier, CA. These studies are seeking a combined 434 participants. Research is being sponsored by Merck Sharp & Dohme LLC, AVM Biotechnology Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Whittier — FAQ
Are there lymphoma clinical trials in Whittier?
Yes, there are 2 lymphoma clinical trials currently recruiting in Whittier, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Whittier?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Whittier research site will contact you about next steps.
Are clinical trials in Whittier free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Whittier studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Whittier are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov